Cargando…
Effective assay technologies fit for large-scale population screening of type 1 diabetes
While worldwide prevention efforts for type 1 diabetes (T1D) are underway to abrogate or slow progression to diabetes, mass screening of islet autoantibodies (IAbs) in the general population is urgently needed. IAbs, the most reliable biomarkers, play an essential role in prediction and clinical dia...
Autores principales: | Jia, Xiaofan, Yu, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012058/ https://www.ncbi.nlm.nih.gov/pubmed/36992730 http://dx.doi.org/10.3389/fcdhc.2022.1034698 |
Ejemplares similares
-
Making Diabetes Care Fit—Are We Making Progress?
por: Ruissen, Merel M., et al.
Publicado: (2021) -
Barriers to and enablers of type 2 diabetes screening among women with prior gestational diabetes: A qualitative study applying the Theoretical Domains Framework
por: Lake, Amelia J., et al.
Publicado: (2023) -
Apparent Insulin Deficiency in an Adult African Population With New-Onset Type 2 Diabetes
por: Kibirige, Davis, et al.
Publicado: (2022) -
A Spanish-language translation for the U.S. of the type 2 diabetes stigma assessment scale (DSAS-2 Spa-US)
por: Joiner, Kevin L., et al.
Publicado: (2022) -
The effectiveness of digital health technologies for patients with diabetes mellitus: A systematic review
por: Stevens, Sebastian, et al.
Publicado: (2022)